11/08/2024
3:15 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
8:24 AM | Day One Biopharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
11/07/2024
8:12 AM | Day One Biopharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
11/04/2024
4:24 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:48 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
4:53 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
4:59 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/19/2024
5:07 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
5:12 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
4:17 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024
4:23 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024
6:35 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
6:04 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2024
5:04 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2024
3:32 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/05/2024
5:11 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
6:17 PM | Day One Biopharmaceuticals (Issuer)
Ramasastry Saira (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
3:14 PM | Day One Biopharmaceuticals (Subject)
Ramasastry Saira (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024
7:36 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2024
3:29 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
7:07 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2024
7:35 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
5:44 PM | Day One Biopharmaceuticals (Issuer)
Grossman William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
5:48 PM | Day One Biopharmaceuticals (Issuer)
Garland J. Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
5:24 PM | Day One Biopharmaceuticals (Issuer)
Josey John A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
5:27 PM | Day One Biopharmaceuticals (Issuer)
Nicholson Garry A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
5:31 PM | Day One Biopharmaceuticals (Issuer)
Ramasastry Saira (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
5:13 PM | Dable Habib J (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
5:17 PM | Day One Biopharmaceuticals (Issuer)
Gladstone Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
5:21 PM | Day One Biopharmaceuticals (Issuer)
Holles Natalie C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
3:02 PM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2024
5:11 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
5:15 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
5:18 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
5:27 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:21 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
5:29 PM | Day One Biopharmaceuticals (Subject)
York Charles N II (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
5:34 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
5:43 PM | Day One Biopharmaceuticals (Subject)
Dubow Adam (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/14/2024
5:13 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:35 PM | Day One Biopharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
The Tesla Trade Is Back In Business (Ad) If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows…
But according to our one expert, new yearly highs are on the horizon…
In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker.
Which is why we’re emailing you now…
You see, most people will simply buy shares of Tesla ahead of the election…
But as they say “There is more than one way to skin a cat”
In fact, we’ve found another way to play shares of Tesla. Discover how to trade Tesla, simply follow this link here. |
05/06/2024
3:30 PM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
5:44 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
5:48 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2024
7:01 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2024
5:36 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
5:09 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:24 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:55 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
5:48 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
5:36 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
5:14 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
5:26 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
4:51 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
7:50 AM | Day One Biopharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Day One Biopharmaceuticals (Subject)
| Form SC 13G | |
01/19/2024
4:19 PM | Dable Habib J (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
4:22 PM | Day One Biopharmaceuticals (Issuer)
Grossman William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
4:01 PM | Dable Habib J (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/19/2024
4:09 PM | Day One Biopharmaceuticals (Issuer)
Grossman William (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/17/2024
7:25 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
6:25 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
6:29 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
6:17 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
6:22 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
7:30 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:06 PM | Day One Biopharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/17/2023
5:20 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
5:26 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
5:30 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
5:33 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
6:07 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free DAWN Stock Alerts